TableĀ 2

Subset analyses

EndpointBMS ISRDES ISR
MACE0.46 (0.30 to 0.70); p<0.0010.41 (0.18 to 0.93); p=0.032
TLR0.22 (0.07 to 0.71); p=0.0180.48 (0.21 to 1.06); p=0.068
Binary restenosis0.21 (0.07 to 0.58); p=0.0030.33 (0.14 to 0.81); p=0.016
Comparator Taxus stentComparator POBA
MACE0.77 (0.27 to 2.18), p=0.6240.44 (0.32 to 0.60); p<0.001
TLR0.89 (0.21 to 3.67); p=0.8670.31 (0.15 to 0.62); p=0.001
Binary restenosis0.69 (0.22 to 2.14); p=0.5200.26 (0.13 to 0.49); p<0.001
  • BMS ISR, in-stent restenosis in a bare-metal stent; DES, ISR in a drug-eluting stent; MACE, major adverse cardiac events; POBA, plain old balloon angioplasty; RR, relative risk (and 95% CIs); TLR, target lesion revascularisation.